[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368432-105":59,"doc-detail-368432-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","artificial-intelligencedriven-microsatellite-instability-profiling-reveals-distinctive-genetic-features-in-patients-with-lung-cancer","Artificial intelligence–driven microsatellite instability profiling reveals distinctive genetic features in patients with lung cancer","","Microsatellite instability (MSI) is a predictive biomarker for immunotherapy, yet its relevance in non–small cell lung cancer (NSCLC) remains unclear. This study uses the bioinformatics tool MIAmS to infer microsatellite status from next-generation sequencing (NGS) with a tailored microsatellite score and performs immunohistochemistry to compare MSI with deficient mismatch repair (dMMR). In 1547 patients, MSI/dMMR cases are rare, and MSI is linked to smoking history and high tumor mutation burden.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/artificial-intelligencedriven-microsatellite-instability-profiling-reveals-distinctive-genetic-features-in-patients-with-lung-cancer/368432/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/artificial-intelligencedriven-microsatellite-instability-profiling-reveals-distinctive-genetic-features-in-patients-with-lung-cancer/368432.png","ImageObject",300,407,{"name":92,"@type":93},"Jacob","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this study in lung cancer patients?","Question",{"text":112,"@type":113},"To determine how MSI and dMMR status can be profiled using NGS-based bioinformatics and immunohistochemistry, and to describe associated clinical and molecular features in NSCLC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were microsatellite status and dMMR assessed?",{"text":117,"@type":113},"Microsatellite status was assessed from next-generation sequencing data using the MIAmS tool with a tailored microsatellite score, and immunohistochemistry was used to evaluate MSI correspondence with dMMR.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about the frequency of MSI/dMMR in the cohort?",{"text":121,"@type":113},"MSI was identified in 8 of 1547 patients (0.52%), and 6 of those also showed dMMR by IHC; MSI/dMMR was characterized as exceedingly rare in lung cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368432,1790219188,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","DOI: 10. 1002/cncr.35882  \nORIGINAL ARTICLE  \nArtificial intelligence–driven microsatellite instability profiling reveals distinctive genetic features in patients with lung cancer  \nQuentin Dominique Thomas MD 1,2  | Julie Adèle Vendrell PhD3 | Lakhdar Khellaf MD4 | Sarah Cavaillon MD1 | Xavier Quantin MD, PhD1,2 | Jérôme Solassol MD, PhD3 | Simon Cabello-Aguilar PhD3,5  \n1Department of Medical Oncology, Institute du Cancer de Montpellier, Montpellier University, Montpellier, France  \n2Oncogenic Pathways in Lung Cancer, Montpellier Cancer Research Institute, University of Montpellier, Montpellier, France 3Solid Tumor Laboratory, Department of Pathology and Oncobiology, Montpellier University Hospital Montpellier, Arnaud de Villeneuve Hospital, Montpellier, France 4Department of Pathology, Institute du Cancer de Montpellier, Montpellier University, Montpellier, France  \n5Montpellier BioInformatics for Clinical Diagnosis, Molecular Medicine and Genomics Platform, Montpellier University Hospital Montpellier, Montpellier, France  \nCorrespondence  \nQuentin Dominique Thomas.  \nEmail: [quentin.thomas@icm.unicancer.fr](quentin.thomas@icm.unicancer.fr)  \nAbstract  \nBackground: Microsatellite instability (MSI) has emerged as a predictive biomarker for immunotherapy response in various cancers, but its role in non–small cell lung cancer (NSCLC) is not fully understood.  \nMethods: The authors used the bioinformatics tool MIAmS to assess microsatellite status from next-generation sequencing (NGS) data using a tailored microsatellite score. Immunohistochemistry (IHC) assays were also performed to evaluate the correspondence between MSI and deficient mismatch repair (dMMR) status. A retrospective analysis of 1547 lung cancer patients was conducted, focusing on those with an MSI phenotype. Clinical characteristics, co-occurring molecular alterations, tumor mutation burden (TMB), and homologous recombination deficiency (HRD) status were evaluated in this subset.  \nResults: Of the 1547 patients analyzed, eight (0.52%) were identified as having MSI through MIAmS, with six (0.39%) of these cases also being dMMR on IHC. All patients with dMMR had an MS score ≥2 and a history of smoking. Most patients showed loss of MLH1 and PMS2 staining on IHC. No correlation was found between MSI status and programmed death-ligand 1 expression, although all MSI patients exhibited high TMB, averaging 21.4 􀀇 5.6 mutations per megabase.  \nDiscussion: MSI/dMMR in lung cancer is exceedingly rare, affecting less than 1% of cases. NGS-based analysis combined with bioinformatics tools provides a robust method to identify MSI/dMMR patients, potentially guiding immunotherapy decisions. This comprehensive approach integrates molecular genotyping and MSI detection, offering personalized treatment options for lung cancer patients. NGSbased MSI testing is emerging as the preferred method for detecting microsatellite instability in various tumor types, including rare cancers.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2025 The Author(s). Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.  \nCancer. 2025;e35882.  \n[https://doi.org/10.1002/cncr.35882](https://doi.org/10.1002/cncr.35882)  \nwi[leyonlinelibrary.com/journal/cncr](leyonlinelibrary.com/journal/cncr)  \n1 of 11  \nKEYWORDS  \nmicrosatellite instability, neuroendocrine tumors, next-generation sequencing, non–small cell lung cancer  \nINTRODUCTION  \nLung cancer is the main cause of cancer-related death worldwide.1 Non–small cell lung cancer (NSCLC) is the most frequent histological type (80%–85%) and is frequently diagnosed at an advanced or metastatic stage.2 Immunotherapy using immune checkpoint-blocking antibodies (ICIs) targeting programmed death-1 or its ligand (PD-1/ PD-L1) ha","cbCaioHZdLFzZHS1","https://ap.wps.com/l/cbCaioHZdLFzZHS1","pdf",1906039,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Discussion\n# Keywords\n# Introduction","[{\"question\":\"What is the main goal of this study in lung cancer patients?\",\"answer\":\"To determine how MSI and dMMR status can be profiled using NGS-based bioinformatics and immunohistochemistry, and to describe associated clinical and molecular features in NSCLC.\"},{\"question\":\"How were microsatellite status and dMMR assessed?\",\"answer\":\"Microsatellite status was assessed from next-generation sequencing data using the MIAmS tool with a tailored microsatellite score, and immunohistochemistry was used to evaluate MSI correspondence with dMMR.\"},{\"question\":\"What did the results show about the frequency of MSI/dMMR in the cohort?\",\"answer\":\"MSI was identified in 8 of 1547 patients (0.52%), and 6 of those also showed dMMR by IHC; MSI/dMMR was characterized as exceedingly rare in lung cancer.\"}]","Artificial intelligence–driven microsatellite instability profiling reveals distinctive genetic features in patients with lung cancer | PDF",1790176926,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20bbcbff6ef2320eb425ffbc894442e7.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b0b23425f44aae931c7a3678d6e1af8.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cef0704b0bb32c9ff6606df6a9b965a7.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e00cf9fe2dd4783b43ac61406166f987.webp",980,1287]